COMPANY PROFILE

Novorex

Explore full profile

Cutting edge technology를 활용한 Seamless Drug Discovery

Sant Cugat del Vallès, SpainFounded 2020Biotech & Life Sciences

Valuation $50–100M Last recorded · 2026

Revenue $1–10M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

About Novorex

NOVOREX IBERICA is a company based out of Spain.

Source: Dealroom company data

Status: Operational
Founded: 2020
Headquarters: Sant Cugat del Vallès, Spain
Employees: 3
Open positions: None listed
Dealroom signal: 26.3/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Founder mafia, market maps, research and news connected to this company by Dealroom

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Apr 2026	$14M	$57M	Hyundai Technology Investment · UTC Investment · SBI Investment Korea · Korea Development Bank	↗
SERIES A✓Equity / VC	Nov 2023	$8.9M	$36M	Hana Ventures · Company K Partners · Woori Venture Partners · Aon	↗

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Novorex website traffic

Latest recorded traffic for Novorex is 400 monthly website visits, down 69.2% over the last three months. Novorex's team grew 0% over the past year.

Latest monthly visits400 3-month web change-69.2% 1-year team growth0%

Monthly website visitsOct 2022–Jun 2026

Summary metrics are public; monthly history is available with a demoCompare with peers →

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ABAiolos BioRevolutionizing the treatment landscape for respiratory disease and other immune conditions	San Francisco, United States	Acquired	3	$245M	$1B
ZDZoo Pharma DynamicsInnovative animal healthcare solutions through advanced research and development	San Antonio, United States	Operational
ALAlderley Lighthouse LabsClinically led laboratory pathology and diagnostic testing services	Macclesfield, United Kingdom	Operational
LTLirum TherapeuticsClinical-stage targeted therapies for oncology and autoimmune diseases	New York City, United States	Operational
AIAlexander Shulgin Research InstituteWe are a psychedelics discovery, development, and educational organization dedicated to continuing and extending the work of Dr. Alexander “Sasha” Shulgin	Lafayette, United States	Operational
BIBioSynchronicityBioSynchronicity has developed the innovative and accurate C-SyncTM COVID-19 Antigen Test	Spokane, United States	Operational
NENENTEREngages in producing, developing, and selling medical intermediates	Jingzhou, China	Acquired
HAHappyDuralThe company develops the first AI-based system, for a personalized sedative drug administration	Tel Aviv-Yafo, Israel	Operational